Impella左心室卸载与VA-ECMO治疗心源性休克患者死亡率降低相关:国际多中心队列研究
本研究基于4国16个中心686例接受VA-ECMO治疗的心源性休克患者数据,经1:1倾向性评分匹配后比较255例联合Impella左心室卸载与255例未卸载患者。结果显示左心室卸载与30天死亡率降低相关(HR 0.79,95%CI 0.63-0.98,P=0.03),但严重出血、入路相关缺血、腹腔间隔室综合征及肾脏替代治疗发生率更高。
要点
- VA-ECMO联合Impella左心室卸载与30天死亡率降低独立相关(HR 0.79)。
- 左心室卸载组严重出血(38.4% vs 17.9%)等并发症发生率更高。
- 结论支持在心源性休克VA-ECMO患者中考虑左心室卸载,需RCT进一步验证。
核心结论
- 在接受VA-ECMO治疗的心源性休克患者中,左心室卸载与30天死亡率降低相关,尽管并发症发生率更高。
研究设计与样本
- 国际多中心回顾性队列研究,纳入4国16个三级中心连续686例接受VA-ECMO治疗的心源性休克患者。
- 采用1:1倾向性评分匹配形成255对队列,以Cox回归模型评估左心室卸载与30天死亡率的关联。
主要发现
- 686例中337例(49%)使用了左心室卸载。
- 匹配队列中左心室卸载与30天死亡率降低相关(HR 0.79,95%CI 0.63-0.98,P=0.03),各亚组间无差异。
- 左心室卸载组并发症更常见:严重出血98例(38.4%)vs 45例(17.9%),入路相关缺血55例(21.6%)vs 31例(12.3%),腹腔间隔室综合征23例(9.4%)vs 9例(3.7%),肾脏替代治疗148例(58.5%)vs 99例(39.1%)。
临床怎么用
- 对于接受VA-ECMO治疗的心源性休克患者,可考虑联合Impella进行左心室卸载以降低30天死亡率。
- 需警惕左心室卸载带来的严重出血、入路相关缺血、腹腔间隔室综合征及肾脏替代治疗需求增加。
局限性
- 本研究为观察性队列研究,存在未测量混杂可能,无法确立因果关系。
- 作者呼吁进一步开展随机对照试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used to treat cardiogenic shock. However, VA-ECMO might hamper myocardial recovery. The Impella unloads the left ventricle. This study aimed to evaluate whether left ventricular unloading in patients with cardiogenic shock treated with VA-ECMO was associated with lower mortality. METHODS: Data from 686 consecutive patients with cardiogenic shock treated with VA-ECMO with or without left ventricular unloading using an Impella at 16 tertiary care centers in 4 countries were collected. The association between left ventricular unloading and 30-day mortality was assessed by Cox regression models in a 1:1 propensity score-matched cohort. RESULTS: Left ventricular unloading was used in 337 of the 686 patients (49%). After matching, 255 patients with left ventricular unloading were compared with 255 patients without left ventricular unloading. In the matched cohort, left ventricular unloading was associated with lower 30-day mortality (hazard ratio, 0.79 [95% CI, 0.63-0.98]; P=0.03) without differences in various subgroups. Complications occurred more frequently in patients with left ventricular unloading: severe bleeding in 98 (38.4%) versus 45 (17.9%), access site-related ischemia in 55 (21.6%) versus 31 (12.3%), abdominal compartment in 23 (9.4%) versus 9 (3.7%), and renal replacement therapy in 148 (58.5%) versus 99 (39.1%). CONCLUSIONS: In this international, multicenter cohort study, left ventricular unloading was associated with lower mortality in patients with cardiogenic shock treated with VA-ECMO, despite higher complication rates. These findings support use of left ventricular unloading in patients with cardiogenic shock treated with VA-ECMO and call for further validation, ideally in a randomized, controlled trial.
引用
- Schrage B, Becher PM, Bernhardt A, et al. Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study. Circulation. 2020. PMID: 33032450. doi:10.1161/CIRCULATIONAHA.120.048792
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。